Podcast: MDS PODCAST: Defining Parkinson's disease

MDS Podcast What are journal editors looking for in a good review?

This is the third episode of the special series focused on the peer review process. In this episode, Dr. Alana Kirby speaks with Dr. Jon Stoessl about what journal editors are looking for in a good review. He provides practical tips for writing an effective peer review.

Read More

MDS Podcast When to accept or decline an invitation to review

For the second episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Günther Deuschl about the crucial first part of the peer review process – identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review.

Read More

MDS Podcast Bilateral focused ultrasound thalamotomy for essential tremor, is it safe?

Prof. Andres Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients. Read the article.

Read More

MDS Podcast Neuropsychiatric features of punding and hobbyism in Parkinson’s disease

Dr. Hugo Morales discusses «Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease,» by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice. Read the article.

Read More

MDS Podcast Approach to neuroimaging in Parkinsonisms

Dr. Sara Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in Movement Disorders Clinical Practice on a «Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.» Read the article

Read More

MDS Podcast Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology

Dr. Günter Hoglinger discusses the article he recently published in the Movement Disorders journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations. Read the article

Read More

MDS Podcast Perampanel may reduce alpha-synuclein transmission in Parkinson’s disease. A possible therapeutic target?

Dr. Michele Matarazzo speaks with Prof. Ryosuke Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. Read the article

Read More

MDS Podcast Variability of movement disorders: The influence of sensation

Dr. Michele Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders journal, highlighting the impact on several factors on the variability of movement disorders. Read the article

Read More

MDS Podcast The most impactful paper related to movement disorders therapy in the 20th century

Dr. Sara Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson’s disease in the 1960s, how that generated an explosion of interest and research in dopamine’s role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that…

Read More